Canal Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Canal Capital Management's BMY Position: Q2 2024 in Review
Canal Capital Management sold out of Bristol-Myers Squibb (BMY) in Q2 2024, closing a stake of 107,340 shares — an estimated $5.82M sold.
Canal Capital Management first reported a position in BMY in Q2 2019 and held it in 20 quarters. The position peaked at $5.82M in Q1 2024. 2,152 funds tracked by Wall St. Rank hold BMY as of Q2 2024.
- Canal Capital Management reported no remaining Bristol-Myers Squibb position as of Q2 2024 after selling out during the quarter.
- Canal Capital Management sold 107,340 Bristol-Myers Squibb shares in Q2 2024, an estimated $5.82M.
- Canal Capital Management first reported a position in Bristol-Myers Squibb in Q2 2019 and held it in 20 quarters.
- Canal Capital Management's Bristol-Myers Squibb position peaked at $5.82M in Q1 2024.
- 2,152 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2024.
Based on Canal Capital Management's 13F filing for Q2 2024, filed 30 Jul 2024.